human il-2 elisa kit (Multi Sciences (Lianke) Biotech Co Ltd)
Multi Sciences (Lianke) Biotech Co Ltd is a verified supplier 
Multi Sciences (Lianke) Biotech Co Ltd manufactures this product 
95
Structured Review
Multi Sciences (Lianke) Biotech Co Ltd
human il-2 elisa kit
Human Il 2 Elisa Kit, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 108 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+2+elisa+kit/Human+IL-2+ELISA+Kit/custom%40ek102%4042628379
Average 95 stars, based on 108 article reviews
Human Il 2 Elisa Kit, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 108 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+2+elisa+kit/Human+IL-2+ELISA+Kit/custom%40ek102%4042628379
Average 95 stars, based on 108 article reviews
human il-2 elisa kit - by Bioz Stars,
2026-11
95/100 stars
Images
Related Articles
Lactate Dehydrogenase Assay:Article Title: Interleukin 21-Armed EGFR-VHH-CAR-T Cell Therapy for the Treatment of Esophageal Squamous Cell Carcinoma Article Snippet: The Cytotoxicity LDH Assay Kit-WST (DOJINDO, Shanghai, China) was used to detect the LDH secretion of KYSE cell lines that were co-cultured with CAR-T cells or UTD T cells at different ratios (T cells: target cells = 2:1, 4:1, 8:1, 16:1, and 32:1). .. After 16 h, the culture supernatants were collected and detected by using an LDH release assay, a human IFN-γ ELISA kit (MultiSciences, Hangzhou, China), a human TNF-α ELISA kit (MultiSciences), a Article Title: Interleukin 21-Armed EGFR-VHH-CAR-T Cell Therapy for the Treatment of Esophageal Squamous Cell Carcinoma. Article Snippet: The Cytotoxicity LDH Assay Kit-WST (DOJINDO, Shanghai, China) was used to detect the LDH secretion of KYSE cell lines that were co-cultured with CAR-T cells or UTD T cells at different ratios (T cells: target cells = 2:1, 4:1, 8:1, 16:1, and 32:1). .. After 16 h, the culture supernatants were collected and detected by using an LDH release assay, a human IFN-γ ELISA kit (MultiSciences, Hangzhou, China), a human TNF-α ELISA kit (MultiSciences), a Enzyme-linked Immunosorbent Assay:Article Title: Interleukin 21-Armed EGFR-VHH-CAR-T Cell Therapy for the Treatment of Esophageal Squamous Cell Carcinoma Article Snippet: The Cytotoxicity LDH Assay Kit-WST (DOJINDO, Shanghai, China) was used to detect the LDH secretion of KYSE cell lines that were co-cultured with CAR-T cells or UTD T cells at different ratios (T cells: target cells = 2:1, 4:1, 8:1, 16:1, and 32:1). .. After 16 h, the culture supernatants were collected and detected by using an LDH release assay, a human IFN-γ ELISA kit (MultiSciences, Hangzhou, China), a human TNF-α ELISA kit (MultiSciences), a Article Title: TNFSF10 drives hyperactive immune responses via NLRP3 inflammasome and endoplasmic reticulum stress in autoimmune and inflammatory diseases. Article Snippet: .. The kits included the QuantiCyto Human IFN-b ELISA kit (Cat. #: EHC026b.48, neobioscience), the QuantiCyto Human IL-29(IFN-k) ELISA kit (Cat. #: EHC015.48, neobioscience), the QuantiCyto Human IFN-a ELISA kit (Cat. #: EHC144a.48, neobioscience), the Human OPG ELISA Kit (Cat. #: ELK1176, ELK Biotechnology), the Human IL-6 ELISA Kit (Cat. #: EK106, Multi Sciences), the Article Title: Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impacting PD-L1 levels in triple-negative breast cancer. Article Snippet: .. The supernatants were collected after 48 hours and examined by Article Title: DNA-Templated Anchoring of Proteins for Programmable Cell Functionalization and Immunological Response. Article Snippet: CellTiter 96® AQueous One Solution Cell Proliferation Assay (MTS) Kit was purchased from Promega. .. Human TNF-α ELISA Kit, Article Title: A programmable protease-based protein secretion platform for therapeutic applications. Article Snippet: Cell-based therapies represent potent enabling technologies in biomedical science.. However, current genetic control systems for engineered-cell therapies are predominantly based on the transcription or translation of therapeutic outputs.. Here we report a protease-based rapid protein secretion system (PASS) that regulates the secretion of pretranslated proteins retained in the endoplasmic reticulum (ER) owing to an ER-retrieval signal. Article Title: METTL14/IGF2BP2-mediated m6A modification of PD-L1 promotes proliferation, metastasis, and immune escape in high-grade gliomas. Article Snippet: N6-methyladenosine (m6A) RNA modification is involved in regulating the malignant progression and immune escape of glioblastoma multiforme (GBM).. This study investigated the role of methyltransferase-like protein 14 (METTL14), the central component of the m6A methylated transferase complex, in GBM progression and immune escape.. METTL14 and programmed death ligand 1 (PD-L1) levels were analyzed by qRT-PCR and Western blot in human GBM samples. Article Title: Validation of CCL20-driven CAR-γδ T secreting PD-1 blockade with enhanced trafficking into solid tumor Article Snippet: LEGEND MAX Human CCL20 ELISA Kit , Biolegend , Cat#: 441407. .. Article Title: Interleukin 21-Armed EGFR-VHH-CAR-T Cell Therapy for the Treatment of Esophageal Squamous Cell Carcinoma. Article Snippet: The Cytotoxicity LDH Assay Kit-WST (DOJINDO, Shanghai, China) was used to detect the LDH secretion of KYSE cell lines that were co-cultured with CAR-T cells or UTD T cells at different ratios (T cells: target cells = 2:1, 4:1, 8:1, 16:1, and 32:1). .. After 16 h, the culture supernatants were collected and detected by using an LDH release assay, a human IFN-γ ELISA kit (MultiSciences, Hangzhou, China), a human TNF-α ELISA kit (MultiSciences), a Transduction:Article Title: A programmable protease-based protein secretion platform for therapeutic applications. Article Snippet: Cell-based therapies represent potent enabling technologies in biomedical science.. However, current genetic control systems for engineered-cell therapies are predominantly based on the transcription or translation of therapeutic outputs.. Here we report a protease-based rapid protein secretion system (PASS) that regulates the secretion of pretranslated proteins retained in the endoplasmic reticulum (ER) owing to an ER-retrieval signal. |
